Ondansetron
Product Images NDC 67296-0386

This product is a box of Ondansetron Orally Disintegrating Tablets, USP, containing 30 tablets with each tablet holding 4 mg of ondansetron. The packaging provides information on the tablet's size, recommended storage conditions, and a warning for Phenylketonurics due to containing phenylalanine. Each tablet needs to be placed on the tongue after being completely removed from the blister pack. For detailed guidance on dosage and administration, refer to the package insert included.*

This text provides information about Ondansetron Orally Disintegrating Tablets, USP, with each tablet containing 8 mg of ondansetron. The artwork size and tablet dimensions are also mentioned. It includes instructions on how to take the tablet and store it properly. Additionally, there is a lot number and expiry date for the product. The text advises against pushing the tablet through foil and directs the user to swallow with saliva. It also contains a warning for phenylketonurics. For further details on dosage and administration, the user is advised to refer to the package insert. The product is identified as a product of India. Contact information for any questions or inquiries is provided, along with the manufacturer's details - Glenmark Pharmaceuticals Inc., USA.*

This text appears to be a list of product codes related to pharmaceutical products, including the name "Ondansetron Tablets, USP", a prescription-only medication. The text also contains references to tablet quantity, a national drug code (NDC) number, and various other codes and contact information which may be related to distribution and manufacturing of the product.*

This is a description of Ondansetron Tablets, USP, available in a pack of 30 tablets. The text includes a mention of the National Drug Code (NDC) 68462-106-30 and indicates that this medication is prescription-only. It also features various characters and words that do not form coherent English text, suggesting scanning errors.*